ENTERIC SOLID ORAL DOSAGE FORM OF BISPHOSPHONATE CONTAINING CHELATING AGENT

ENTERIC SOLID ORAL DOSAGE FORM OF BISPHOSPHONATE CONTAINING CHELATING AGENT

PROBLEM TO BE SOLVED: To provide delivery of a pharmaceutical composition to the lower gastrointestinal tract of a mammal subject and pharmaceutically effective absorption of bisphosphonate with or without a food or a beverage. SOLUTION: There is provided an oral dosage form of bisphosphonate compri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BURGIO DAVID ERNEST JR, DANSEREAU RICHARD JOHN
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BURGIO DAVID ERNEST JR
DANSEREAU RICHARD JOHN
description PROBLEM TO BE SOLVED: To provide delivery of a pharmaceutical composition to the lower gastrointestinal tract of a mammal subject and pharmaceutically effective absorption of bisphosphonate with or without a food or a beverage. SOLUTION: There is provided an oral dosage form of bisphosphonate comprised of a safe and effective amount of the pharmaceutical composition comprising bisphosphonate, a chelating agent, and a means for effecting delayed release of both bisphosphonate and the chelating agent in the lower gastrointestinal tract. COPYRIGHT: (C)2011,JPO&INPIT
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2010275319A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2010275319A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2010275319A3</originalsourceid><addsrcrecordid>eNrjZPB29QtxDfJ0Vgj29_F0UfAPcvRRcPEPdnR3VXDzD_JV8HdTcPIMDvDwB2E_xxBXBWd_vxBHTz9PP3cFZw9XH8cQEAuo3i-Eh4E1LTGnOJUXSnMzKLm5hjh76KYW5MenFhckJqfmpZbEewUYGRgaGJmbGhtaOhoTpQgA1-UuAA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ENTERIC SOLID ORAL DOSAGE FORM OF BISPHOSPHONATE CONTAINING CHELATING AGENT</title><source>esp@cenet</source><creator>BURGIO DAVID ERNEST JR ; DANSEREAU RICHARD JOHN</creator><creatorcontrib>BURGIO DAVID ERNEST JR ; DANSEREAU RICHARD JOHN</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide delivery of a pharmaceutical composition to the lower gastrointestinal tract of a mammal subject and pharmaceutically effective absorption of bisphosphonate with or without a food or a beverage. SOLUTION: There is provided an oral dosage form of bisphosphonate comprised of a safe and effective amount of the pharmaceutical composition comprising bisphosphonate, a chelating agent, and a means for effecting delayed release of both bisphosphonate and the chelating agent in the lower gastrointestinal tract. COPYRIGHT: (C)2011,JPO&amp;INPIT</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101209&amp;DB=EPODOC&amp;CC=JP&amp;NR=2010275319A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20101209&amp;DB=EPODOC&amp;CC=JP&amp;NR=2010275319A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BURGIO DAVID ERNEST JR</creatorcontrib><creatorcontrib>DANSEREAU RICHARD JOHN</creatorcontrib><title>ENTERIC SOLID ORAL DOSAGE FORM OF BISPHOSPHONATE CONTAINING CHELATING AGENT</title><description>PROBLEM TO BE SOLVED: To provide delivery of a pharmaceutical composition to the lower gastrointestinal tract of a mammal subject and pharmaceutically effective absorption of bisphosphonate with or without a food or a beverage. SOLUTION: There is provided an oral dosage form of bisphosphonate comprised of a safe and effective amount of the pharmaceutical composition comprising bisphosphonate, a chelating agent, and a means for effecting delayed release of both bisphosphonate and the chelating agent in the lower gastrointestinal tract. COPYRIGHT: (C)2011,JPO&amp;INPIT</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPB29QtxDfJ0Vgj29_F0UfAPcvRRcPEPdnR3VXDzD_JV8HdTcPIMDvDwB2E_xxBXBWd_vxBHTz9PP3cFZw9XH8cQEAuo3i-Eh4E1LTGnOJUXSnMzKLm5hjh76KYW5MenFhckJqfmpZbEewUYGRgaGJmbGhtaOhoTpQgA1-UuAA</recordid><startdate>20101209</startdate><enddate>20101209</enddate><creator>BURGIO DAVID ERNEST JR</creator><creator>DANSEREAU RICHARD JOHN</creator><scope>EVB</scope></search><sort><creationdate>20101209</creationdate><title>ENTERIC SOLID ORAL DOSAGE FORM OF BISPHOSPHONATE CONTAINING CHELATING AGENT</title><author>BURGIO DAVID ERNEST JR ; DANSEREAU RICHARD JOHN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2010275319A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BURGIO DAVID ERNEST JR</creatorcontrib><creatorcontrib>DANSEREAU RICHARD JOHN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BURGIO DAVID ERNEST JR</au><au>DANSEREAU RICHARD JOHN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ENTERIC SOLID ORAL DOSAGE FORM OF BISPHOSPHONATE CONTAINING CHELATING AGENT</title><date>2010-12-09</date><risdate>2010</risdate><abstract>PROBLEM TO BE SOLVED: To provide delivery of a pharmaceutical composition to the lower gastrointestinal tract of a mammal subject and pharmaceutically effective absorption of bisphosphonate with or without a food or a beverage. SOLUTION: There is provided an oral dosage form of bisphosphonate comprised of a safe and effective amount of the pharmaceutical composition comprising bisphosphonate, a chelating agent, and a means for effecting delayed release of both bisphosphonate and the chelating agent in the lower gastrointestinal tract. COPYRIGHT: (C)2011,JPO&amp;INPIT</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2010275319A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ENTERIC SOLID ORAL DOSAGE FORM OF BISPHOSPHONATE CONTAINING CHELATING AGENT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T21%3A04%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BURGIO%20DAVID%20ERNEST%20JR&rft.date=2010-12-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2010275319A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true